European Radiology:从影像学角度,明确特发性炎症性肌病与特异性自身抗体之间的关系

2022-03-11 shaosai MedSci原创

特发性炎症性肌病(IIMs)是一组罕见的、异质性的多系统自身免疫性疾病,以骨骼肌、皮肤和其他器官受累为主要特征。间质性肺病(ILD)是最常见的肌肉外IIM受累表现之一。

特发性炎症性肌病(IIMs)是一组罕见的、异质性的多系统自身免疫性疾病,以骨骼肌、皮肤和其他器官受累为主要特征。间质性肺病(ILD)是最常见的肌肉外IIM受累表现之一。

虽然IIM的ILD很少进行活检,但非特异性间质性肺炎(NSIP)是获得组织病理学模式的重要途径,也可显示弥漫性肺泡损伤(DAD)和组织性肺炎(OP)的存在及范围。在高分辨率计算机断层扫描(CT)中,双网状结构和磨玻璃密度是肌炎相关ILD最常见的特征,但也有表现为实变的区域存在。据我们所知,到目前为止,还没有研究人员对不同的CT-ILD结果及其与不同的IIM亚组之间的关系进行具体分析。

近日,发表在European Radiology杂志的一项研究通过分析不同的CT表现及其与不同IIM和MSA的潜在关系,来确定不同的CT-ILD模式,并评估放射科医生对这些模式识别的可重复性

本研究对所有连续的IIM患者(2003-2019年)进行了分析两位胸部放射学专家回顾性所有胸部CT图像进行评估。CT表现的多重对应和分层聚类分析ILD患者的亚群进行确认并使其具有特征性。分类和回归树分析强调了预测三种模式的CT扫描变量。三位独立的放射科医生CT扫描进行二次阅读,根据CT-ILD模式群对患者进行分配。 

在257名IIM患者中,94人(36.6%)有ILD;其中87人(93%)为MSA阳性。ILD-IIM的分布是54(57%)ASyS,21(22%)DM,15(16%)IMNM,和4(4%)IBM。聚类分析确定了三个ILD患者亚群。集群1的特点是抗MDA5自体抗体阳性的情况明显增多(P < 0.05)。第2组患者有明显更多的网格样改变,没有囊,合并的情况也很少。所有第3组患者都有囊和抗PL12自身抗体。第2群和第3群包括明显更多的ASyS患者。将病人归入这三个群组的观察者内部一致性很好,甚至很好(Cohen κ 0.64-0.81),观察者之间的可靠性很好(Fleiss's κ 0.56)。 

 30岁女性,a 轴位和b矢状位薄层CT图像显示胸膜下肺囊肿,伴有一些小面积的磨玻璃样密度。c 58岁女性,轴薄层CT图像,显示双侧胸膜下蜂窝状改变

总之,在IIM患者中显示的ILD异质性,可将患者的CT表现可分为三组。由放射科医生确定的与MSA明显相关的CT表现,具有良好的观察者内重复性和测量者间可靠性

原文出处

Amandine Laporte,Kubéraka Mariampillai,Yves Allenbach,et al.Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.DOI:10.1007/s00330-021-08411-w

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1899546, encodeId=bce01899546af, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 07 12:10:12 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894842, encodeId=093c18948422f, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Mon Apr 11 06:10:12 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724385, encodeId=d90a1e243854d, content=<a href='/topic/show?id=13896e88231' target=_blank style='color:#2F92EE;'>#特发性炎症性肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67882, encryptionId=13896e88231, topicName=特发性炎症性肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=397a33615269, createdName=bbjsj_1990, createdTime=Sun Jul 24 13:10:12 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729422, encodeId=d0611e29422d0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jan 28 07:10:12 CST 2023, time=2023-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547529, encodeId=ab2f154e5299b, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622525, encodeId=8c13162252506, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201772, encodeId=3cd01201e72dc, content=好东西,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Fri Mar 11 20:04:20 CST 2022, time=2022-03-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1899546, encodeId=bce01899546af, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 07 12:10:12 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894842, encodeId=093c18948422f, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Mon Apr 11 06:10:12 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724385, encodeId=d90a1e243854d, content=<a href='/topic/show?id=13896e88231' target=_blank style='color:#2F92EE;'>#特发性炎症性肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67882, encryptionId=13896e88231, topicName=特发性炎症性肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=397a33615269, createdName=bbjsj_1990, createdTime=Sun Jul 24 13:10:12 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729422, encodeId=d0611e29422d0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jan 28 07:10:12 CST 2023, time=2023-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547529, encodeId=ab2f154e5299b, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622525, encodeId=8c13162252506, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201772, encodeId=3cd01201e72dc, content=好东西,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Fri Mar 11 20:04:20 CST 2022, time=2022-03-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1899546, encodeId=bce01899546af, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 07 12:10:12 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894842, encodeId=093c18948422f, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Mon Apr 11 06:10:12 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724385, encodeId=d90a1e243854d, content=<a href='/topic/show?id=13896e88231' target=_blank style='color:#2F92EE;'>#特发性炎症性肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67882, encryptionId=13896e88231, topicName=特发性炎症性肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=397a33615269, createdName=bbjsj_1990, createdTime=Sun Jul 24 13:10:12 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729422, encodeId=d0611e29422d0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jan 28 07:10:12 CST 2023, time=2023-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547529, encodeId=ab2f154e5299b, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622525, encodeId=8c13162252506, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201772, encodeId=3cd01201e72dc, content=好东西,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Fri Mar 11 20:04:20 CST 2022, time=2022-03-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1899546, encodeId=bce01899546af, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 07 12:10:12 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894842, encodeId=093c18948422f, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Mon Apr 11 06:10:12 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724385, encodeId=d90a1e243854d, content=<a href='/topic/show?id=13896e88231' target=_blank style='color:#2F92EE;'>#特发性炎症性肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67882, encryptionId=13896e88231, topicName=特发性炎症性肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=397a33615269, createdName=bbjsj_1990, createdTime=Sun Jul 24 13:10:12 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729422, encodeId=d0611e29422d0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jan 28 07:10:12 CST 2023, time=2023-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547529, encodeId=ab2f154e5299b, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622525, encodeId=8c13162252506, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201772, encodeId=3cd01201e72dc, content=好东西,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Fri Mar 11 20:04:20 CST 2022, time=2022-03-11, status=1, ipAttribution=)]
    2023-01-28 feather89
  5. [GetPortalCommentsPageByObjectIdResponse(id=1899546, encodeId=bce01899546af, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 07 12:10:12 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894842, encodeId=093c18948422f, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Mon Apr 11 06:10:12 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724385, encodeId=d90a1e243854d, content=<a href='/topic/show?id=13896e88231' target=_blank style='color:#2F92EE;'>#特发性炎症性肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67882, encryptionId=13896e88231, topicName=特发性炎症性肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=397a33615269, createdName=bbjsj_1990, createdTime=Sun Jul 24 13:10:12 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729422, encodeId=d0611e29422d0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jan 28 07:10:12 CST 2023, time=2023-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547529, encodeId=ab2f154e5299b, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622525, encodeId=8c13162252506, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201772, encodeId=3cd01201e72dc, content=好东西,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Fri Mar 11 20:04:20 CST 2022, time=2022-03-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1899546, encodeId=bce01899546af, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 07 12:10:12 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894842, encodeId=093c18948422f, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Mon Apr 11 06:10:12 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724385, encodeId=d90a1e243854d, content=<a href='/topic/show?id=13896e88231' target=_blank style='color:#2F92EE;'>#特发性炎症性肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67882, encryptionId=13896e88231, topicName=特发性炎症性肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=397a33615269, createdName=bbjsj_1990, createdTime=Sun Jul 24 13:10:12 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729422, encodeId=d0611e29422d0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jan 28 07:10:12 CST 2023, time=2023-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547529, encodeId=ab2f154e5299b, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622525, encodeId=8c13162252506, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201772, encodeId=3cd01201e72dc, content=好东西,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Fri Mar 11 20:04:20 CST 2022, time=2022-03-11, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1899546, encodeId=bce01899546af, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 07 12:10:12 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1894842, encodeId=093c18948422f, content=<a href='/topic/show?id=e45b6e859f3' target=_blank style='color:#2F92EE;'>#特发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67859, encryptionId=e45b6e859f3, topicName=特发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Mon Apr 11 06:10:12 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724385, encodeId=d90a1e243854d, content=<a href='/topic/show?id=13896e88231' target=_blank style='color:#2F92EE;'>#特发性炎症性肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67882, encryptionId=13896e88231, topicName=特发性炎症性肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=397a33615269, createdName=bbjsj_1990, createdTime=Sun Jul 24 13:10:12 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729422, encodeId=d0611e29422d0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jan 28 07:10:12 CST 2023, time=2023-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547529, encodeId=ab2f154e5299b, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622525, encodeId=8c13162252506, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun Mar 13 04:10:12 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201772, encodeId=3cd01201e72dc, content=好东西,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Fri Mar 11 20:04:20 CST 2022, time=2022-03-11, status=1, ipAttribution=)]
    2022-03-11 萌宝嘟嘟

    好东西,谢谢分享!

    0

相关资讯

ARD:MUC5B突变携带者类风湿性关节炎相关间质性肺病的终生风险

间质性肺病(ILD)是其中一种最常见的类风湿性关节炎(RA)关节外并发症。根据已知最强的肺纤维化风险因素(一种MUC5B启动子突变),评估发生类风湿性关节炎相关间质性肺病(RA-ILD)的终生风险。

类风湿关节炎相关间质性肺病的影像学特征

间质性肺病(ILD)是类风湿关节炎(RA)最常见的肺部表现。RA-ILD的临床表现和发病机制与特发性间质性肺炎(IIP)相似。

Thorax:外周血白细胞端粒长度与系统性硬化症间质性肺病进展相关

这些结果表明端粒功能障碍可能与SSc-ILD进展相关,并且PBL-TL测量可能有助于对SSc-ILD进展风险进行分层。

ARD:肺分子特征的综合分析揭示了系统性硬化症相关间质性肺病的关键驱动因素

肺组织的综合转录组分析揭示了 SSc-ILD 中纤维化的关键特征。基于网络的贝叶斯方法提供了对适用于治疗 SSc-ILD 的关键调控基因和分子靶点的深入见解。

A&R:干扰素基因刺激因子的增强在COPA综合征中诱导I型干扰素的产生

V242G是在一个家庭的4名患者中发现的新型COPA突变。在具有V242G突变的基因靶向小鼠中出现了间质性肺病,STING途径的反应增强,导致I型IFN产生增加。

Eur Respir J:细颗粒物成分与类风湿性关节炎患者间质性肺病的关系

暴露于PM2.5的组分,尤其是铵,会增加类风湿性关节炎患者的ILD风险。